FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue ...
Western Digital Reports Mixed Q2 Ahead Of Business Split: AI Demand Bolsters Outlook
Western Digital which will be splitting its business by the end of February remains confident to benefit from the rising AI ...